Alarin and Adipsin, which play an important role in the pathophysiology of diabetes and obesity, and have a regulatory role in hyperglycemia and insulin resistance, can be considered for use in the treatment of diabetes and associated complications. The gene discussed is CFD; the disease is obesity due to melanocortin 4 receptor deficiency.